Society of Toxicology 2012

March 11-15, 2012 in San Francisco, CA

The Society of Toxicology (SOT) Annual Meeting is the largest toxicology meeting and exhibition in the world, attracting more than 6,500 scientists from industry, academia, and government from various countries around the globe. From the keynote address and special lectures, to a wide range of symposia sessions to continuing education courses that cover the basic and the advanced topics of the day, to the workshops, thematic sessions that complement the symposia, roundtables, poster sessions, and award presentations, SOT’s Annual Meeting has something for every attendee.

Look for CeeTox at Booth 1909 at the SOT’s ToxExpo 2012 in San Francisco, CA, from March 11-15, 2012. SOT’s Annual Meeting is the forum to showcase toxicology’s novel discoveries.

We welcome the chance to sit down and learn about your latest tox challenges. Please contact info@ceetox.com to set up a personal meeting with us.

Visit the ToxExpo 2012 website.

ACT – American College of Toxicology 32nd Annual Meeting

November 6-8, 2011 in Phoenix, AZ

Join us for the 31st Annual Meeting of the American College of Toxicology (ACT) at the Arizona Biltmore Resort & Spa Nov. 6-8, 2011. The mission of ACT is to educate, lead and serve professionals in industry, government and academia by promoting the exchange of information and perspectives on safety assessment and the application of new developments related to toxicology.

CeeTox will be exhibiting at booth 003.

Visit the ACT 2011 Annual Meeting website.

Cosmetic Science EXPO 2011

October 26-27, 2011 in Newark, NJ

Plan to attend the Cosmetic Science EXPO, held in conjunction with the 2011 Science Symposium. The event is sponsored by the Personal Care Products Council and will be held at the Marriott Newark International Hotel in Newark, NJ. Workshops will include:
Microbiology
Quality Assurance
Safety
Environmental

Stop by the CeeTox booth to see what is new in in vitro testing services.

Visit the Cosmetic Science EXPO 2011 web site.

CELLTOX – International Congress on In Vitro Toxicology

October 19-21, 2011 in Rome, Italy

In vitro toxicology has grown and acquired a major importance over the last two decades, both for the scientific advancements in this field and for the increasing influence of its approaches on the regulatory bodies. This Congress will provide a forum for presenting novel approaches and recent results and to exchange ideas among leading scientists and young researchers. A poster session will allow a wider discussion among all participants. This event will be held at istituto Superiore de Sanita – Viale Regina Elena, 299 in Rome, Italy. The official language of the meeting will be English.

Visit the CELLTOX 2011 website.

Visit us at Booths 13 and 14
Visit the WC8 website

New York Society of Cosmetic Chemists Suppliers’ Day 2011

May 10-11, 2011 in Edison, NJ

This exhibition is a chance to see the newest cosmetics and personal care products and discuss the latest innovations with technical, marketing, and business associates from around the world. The NYSCCS Suppliers’ Day in now the largest even of its kind in the world.

CeeTox will be exhibiting at this event and Brent Gilbert, Account Manager for Personal Care, will be in attendance. See us at Booth 1669.

This show will again be held at The New Jersey Convention and Exposition Center, Raritan Center, 97 Sunfield Avenue, in Edison, NJ.

Visit the NYSCC Suppliers’ Day website.

IVTIP Spring 2011 Meeting

April 26-27, 2011 in Monte Carlo, Monaco

The Spring meeting of IVTIP (In Vitro Testing Industrial Platform) is in collaboration with ESTIV (European Society of Toxicology In Vitro) and CAAT (Center for Alternatives to Animal Testing). The title is “In vitro reconstructed human tissue models as alternatives to animal testing: applicability and limitations.”

Dr. James McKim of CeeTox will be attending this conference. Sign up early – there is a limit of 150 attendees. Presentations will be April 26 and 27. The last day of the conference is for IVTIP members only.

The meeting will be held at Novotel in Monte Carlo, Monaco. To learn more, visit the meeting web site at IVTIP-ESTIV-CAAT

Meeting registration form

Hotel reservation form

in-cosmetics 2011

March 29-31, 2011 in Milan, Italy

CeeTox will be exhibiting in Space B93 at in-cosmetics to be held at Fiera Milano, Milan, Italy March 29-31, 2011. The Cosmetic Science Conference will be your opportunity to learn from industry experts.

CeeTox, a world-class provider of in vitro toxicology services operating under GLP-guidelines, is pleased to offer a full battery of Endocrine Disruption Screening services. In addition to the ability to detect compounds that activate or antagonize androgen and estrogen receptors, we are able to quantitatively assess specific binding to these receptors, greatly reducing spurious results. To complement these services, we also perform assays directed at determining perturbations in the steroidogenesis pathway, including aromatase. CeeTox also offers a variety of acute and organ-specific toxicity screens, dermal and ocular irritation, absorption and sensitization services.

Staged annually in spring in a major European city, in-cosmetics brings together the world’s leading cosmetics suppliers, R&D, production and marketing specialists and showcases the most diverse range of new and innovative cosmetics ingredients and services. Offering a crucial insight into future scientific advances, emerging trends and regulations in an unrivaled educational program, in-cosmetics is the most comprehensive source of industry expertise and the most effective formula for developing business opportunities.

Visit the in-cosmetics website.

AAPS Workshop on Drug Transporters in ADME

March 14-16, 2011 in Bethesda, MD

Recognition of the influence of membrane transporters on drug disposition has driven a surge in related research within the pharmaceutical sciences. Drug transport research continues to evolve rapidly, with advances in understanding the role of transport in drug absorption, distribution, and excretion, as well as toxicity and disease. Although considerable progress has been made over the past 15 years, the field of drug transport continues to evolve, particularly with respect to clinical translation of in vitro/preclinical data, understanding systemic/tissue exposure implications, toxicity/disease pathogenesis, targeting transport for drug delivery, and interplay with metabolism.

This fifth biennial AAPS Workshop aims to build on the success of previous meetings and provide an opportunity for pharmaceutical, academic and regulatory scientists to exchange ideas about transporter research.

CeeTox’s Dr. Phil Burton, an expert in ADME and transporters, will be attending this workshop.

Visit the AAPS Workshop on Drug Transporters in ADME website.

Society of Toxicology 2011

March 7-9, 2011 in Washington, DC

The Society of Toxicology (SOT) Annual Meeting is the largest toxicology meeting and exhibition in the world, attracting more than 6,500 scientists from industry, academia, and government from various countries around the globe. From the keynote address and special lectures, to a wide range of symposia sessions to continuing education courses that cover the basic and the advanced topics of the day, to the workshops, thematic sessions that complement the symposia, roundtables, poster sessions, and award presentations, SOT’s Annual Meeting has something for every attendee.

Look for CeeTox at Booth 307 at the SOT’s ToxExpo 2011 in Washington, DC, from March 7-9, 2011. SOT’s Annual Meeting is the forum to showcase toxicology’s novel discoveries.

We will also be presenting four posters:

Determining Skin Sensitization Potential of Medical Device Materials Using a New In Vitro Method

978 Poster Board – 137
Presented by Don Keller
Alternative Approaches to Animal Testing for Toxicological Research
March 8, 2011: 9:00am – 12:30pm
Exhibit Hall (Convention Center)

Developing an In Vitro Model to Determine Kidney Specific Toxicity (KST)

2544 Poster Board – 138
Presented by Jeffrey Pregenzer
Alternatives to Animal Models in Toxicology
March 10, 2011: 8:30am – 12:00pm
East Registration Area (Convention Center)

A New In Vitro Model for Identifying Liver Specific Toxicity (LST)

2543 Poster Board -137
Presented by James McKim
Alternatives to Animal Models in Toxicology
March 10, 2011: 8:30am – 12:00pm
East Registration Area (Convention Center)

Validation Results and Methods for Improving In Vitro Tier 1 Endocrine Disruption Screening Assays

2559 Poster Board -153
Presented by Colleen Toole
Alternatives to Animal Models in Toxicology
March 10, 2011: 8:30am – 12:00pm
East Registration Area (Convention Center)

Additionally, two other posters presented by L’Oreal will feature work done in collaboration with CeeTox:

Development of An Integrative Approach for the Prediction of Systemic Toxicity: Combination of Cell Toxicity, Pharmacological, and Physical Chemical Properties

2512 Poster Board -104
March 10, 2011: 8:30am – 12:00pm
East Salon Area (Convention Center)

Evaluation of SensCeeTox®: An Integrative Model for Identifying Chemical Sensitizers

2513 Poster Board -105
March 10, 2011: 8:30am – 12:00pm
East Salon Area (Convention Center)

We welcome the chance to sit down and learn about your latest tox challenges. Please contact info@ceetox.com to set up a personal meeting with us.

Visit the ToxExpo 2011 website.

Endocrine Disruptors 2011

February 8-9, 2011 in Zurich, Switzerland

iSmithers inaugural Endocrine Disruptors 2011 conference will address key topics related to the evaluation of adverse effects on the endocrine system and corresponding regulatory requirements. It will bring together experts from academia, government, and industry to focus on current and future trends in testing, interpretation and evaluation of test results and how this relates to or influences regulaatory activities.

Dr. Colleen Toole, CeeTox Director of Project Management, will be presenting “Validation results and methods for improving in vitro tier 1 endocrine disruption screening assays” at Session 4 on Wednesday, February 9, 2011 at 10:30 am.

Visit the Endocrine Disruptors 2011 web site.

AAPS – American Association of Pharmaceutical Scientists

Nov. 14-17, 2010 in New Orleans, LA

Every three to four years, the International Pharmaceutical Federation (FIP) organizes a Pharmaceutical Sciences World Congress (PSWC). Each year, the American Association of Pharmaceutical Scientists (AAPS) organizes the AAPS Annual Meeting and Exposition.

In 2010 FIP and AAPS will hold the PSWC and the Annual Meeting together in New Orleans, LA at the Morial Convention Center from November 14–18 (The expo runs from Nov. 14-17). The scientific theme is: Improving Global Health Through Advances in Pharmaceutical Sciences.

The joint meeting will include:
• A forum for the exchange of ideas and information about the sciences that the
organizations represent
• Continuing professional development for individual members and related professionals
• An introduction of the latest technological advances

Visit CeeTox at Booth 3144. Note change from number assigned earlier.

Visit the AAPS website.

ACT – American College of Toxicology

Nov. 7-10, 2010 in Baltimore, MD

Join us for the 31st Annual Meeting of the American College of Toxicology (ACT) at the Baltimore Marriott Waterfront Hotel Nov. 7-10, 2010. The mission of ACT is to educate, lead and serve professionals in industry, government and academia by promoting the exchange of information and perspectives on safety assessment and the application of new developments related to toxicology.

CeeTox will be exhibiting at booth 158.

Visit the ACT 2010 Annual Meeting and Call for Abstracts website.

Personal Care Products Council Science Symposium

Oct. 27 - 28, 2010 in Newark, NJ

Join CeeTox at the Cosmetic Science EXPO, to be held in conjunction with the PCPC annual Science Symposium. It will be held at the Marriott Newark International Airport Hotel in Newark, NJ. This year it will feature four informative workshops:
Safety Assessment
Quality Assurance
Environmental
Microbiology

Visit the Science Symposium 2010 website.

Society for Biomolecular Sciences – Biomolecular Screening

Octobert 18-19, 2010 in Durham, NC

This SBS symposium addresses the topics of advanced technologies in small molecule and RNAi high-throughput screening with pesentations from academic, government, and industry screeing experts. The meeting will offer a two-day, dual-science track format.

Phil Burton of CeeTox will be presenting a poster titled “Challenges and Strategies in Making Effective Use of Early ADMET Data.”

Track I will provide presentations and discussions on specific screening efforts and technologies, including:
ADME & toxicology screening
Ion channels & 7TM screening
Signal Transduction & Intracellular Target Screening

Track II will feature sessions on RNAi screening and management of academic screening operations, including:
RNAi Screening I
RNAi Screening II
Challenges & Opportunities in Academic Drug Discovery.

To register and for more information, visit the SBS website.

Northland Chapter of the Society of Toxicology

October 7, 2010 in St. Paul, MN

Plan to attend Toxicology Testing: Alternatives for the 21st Century Thursday, Oct. 7, 2010 8:30-3:45 at the Snelling Office Park, Minnesota Department of Health, St. Paul, MN.

The keynote speaker will be Dr. Melvin Andersen, Director of the Divison of Computational Biology at The Hamner Institues for Health Sciences (formerly CIIT). Other speakers include Dr. Jim McKim of CeeTox, Dr. David Dix of the National Center for Computational Toxicology at the U.S. EPA, Dr. Michael Hornung from the U.S. EPA’s Mid-Continent Ecology Division Laboratory, and a representative from People for the Ethical Treatment of Animals.

Registration will begin in mid-September. A small registration fee will be collected at the door. For further information, please contact Catherine F. Jacobson, Ph.D., DABT NLSOT Secretary/Treasurer (cfjacobson@mmm.com).

Predictive In Vitro Models

Sept. 28-29, 2010 in Cambridge, MA

John Cameron of CeeTox will be attending this meeting at the Marriott Courtyard, Cambridge, MA. It will take place Sept. 28-29, 2010.
Some of the topics to be discussed include:
Strengthening the correleaiton between in vitro and in vivo data
Understanding the FDA’s approach to predictive modeling
Choosing the right compounds to take forward
Understanding the mechanisms behind toxic effects

Visit the Predictive In Vitro Models website.

26th International IFSCC (International Federation Societies of Cosmetic Chemists) Congress – Innovation & Responsibility: Cosmetics Forever

Sept. 20-23, 2010 in Buenos Aires, Argentina

Sept. 20-23, 2010
Sheraton Buenos Aires Hotel & Convention Center
Buenos Aires, Argentina

The 26th Congress in 2010 will be showcase for the presentation of research studies. These studies are representative of the high level attained by cosmetic science, which, on the foundations of innovation and responsibility, provides us with more effective, higher technology products, safer for both the consumer and the environment.

Dr. James McKim will be giving both an oral presentation and a poster at this Congress. The oral presentation, A New In Vitro Method for Identifying Skin Sensitizers and Predicting LLNA EC3 Values will be given Wed., Sept. 22 at 10am. The poster to be presented is Predicting Acute Oral Toxicity (LD50) with an In Vitro Cell-Based system. The poster will be displayed from Sept. 21-23.

Visit the IFSCC 2010 web site

http://iccvam.niehs.nih.gov/meetings/BiologicsWksp-2010/BiologicsWksp.htm

The email contact is: niceatm@niehs.nih.gov

The Power of Outsourcing in Early through Preclinical Drug Development

Sept. 9, 2010 in La Jolla, CA

4:30 p.m. to 9:00 p.m
Hyatt Regency
La Jolla, CA

Register today – seating is limited!

The Power of Outsourcing in Early through Preclinical Drug Development

Mark your calendar and plan to join us for a one day Symposium featuring nine senior level pharmaceutical and biotechnology industry speakers in a keynote address, case study presentations and discussions covering hot topics and end-to-end solutions across the drug-development spectrum. The presentations will explore a number of issues related to “Early through Preclinical Drug Development” and features internationally recognized experts in drug discovery and development discussing topics including:

Keynote Topic:
The objective of this presentation is to provide biotech companies the moste effective ways of outsourcing pre-clinical testing. Theses will include identifying the criteria for choosing the appropriate contract lab based on its history, capabilities, expertise, and finally making a choice between science and quality of the product versus cost.

Panel Topics:

Medicinal Chemistry: IP generation, hit validation, lead optimization and solving tough synthetic problems

In Vitro Approaches for Organ Specific Toxicity Screening: A new in vitro approach designed to determine if a drug will cause adverse effects in liver, heart, or kidney. By incorporating a two cell model, organ specific toxicity endpoints, and markers of general cell health that it is possible to identify a drugs potential to cause liver, heart, or kidney toxicity

Challenges Associated with “Metabolomics”: The comprehensive, integrated analytical and data handling platform that provide a chemo-centric global metabolism analyses of biological systems. Presenting a specific case study describing the impact of this platform in a Drug Mechanism of Action Study

“Biologics,” or Large Molecules: Showcasing many significant ways in which the development process of a large molecule differs from that of traditional small molecules, including immune response, dose solution preparatory considerations, species-specific pharmacologic factors, and delivery methods

Chemistry, Manufacturing and Control (CMC): Formulation and analytical development topics along with early phase cGMP clinical supply manufacturing. The presentation will provide participants with the fundamentals needed to successfully implement an early stage CMC development process

Phase I Clinical Pharmacology and Early Clinical Research Studies: Cardiac safety, PK/PD, drug interaction and methodology studies. Incorporating pharmacogenetics and biomarkers into exploratory and proof of concept studies

Agenda:

4:00 p.m. – 5:00 p.m. Registration, Networking & Visiting Exhibit Hall: Complimentary cocktails and horsd’oeuvres will be served
5:00 p.m. – 8:30 p.m.: Panel Presentation
8:30 p.m. -9:00 p.m. Q&A
9:00 p.m. Adjourn

Keynote Speaker:

Ali Faqi, Ph.D., DVM, DABT – MPI

Panel Speakers:

David C. Zimmermann, CEO – Kalexsyn Inc.

James McKim, Ph.D., DABT – CSO, CeeTox Inc

John Ryals, Ph.D. – CEO, Metabolon

David McGee, Ph.D. – MPI

David Barnes, PhD – CSO, Velesco Pharmaceutical

Dean Knuth – CEO, Jasper Clinic

Grace M. Furman, Ph.D., DABT- CEO/President, Paracelsus, Inc.

Sylvie K. Sakata, PhD Senior Director
Pfizer Inc. La Jolla and St Louis
Lead External Research Solutions RCoE

Registration:

Begins on July 12th

There is no charge to attend this conference; however, advance registration is required and space is limited. Interested individuals can register online at IALSN’s website at www.ialsn.org

For advanced reservations, please contact Maryam Famourzadeh at mfamourzadeh@ialsn.org

Sponsorship levels:
Diamond ($1,000.00); Platinum ($400.00), Gold ($200.00), and Silver ($100.00)
To become a sponsor please email us at info@ialsn.org

For more info please visit
www.ialsn.org